Agenus (AGEN) Shares Outstanding (2010 - 2026)
Agenus' (AGEN) quarterly Shares Outstanding (Entity) came in at $29.7 million in Q4 2025, up 25.81% year-on-year from $23.6 million in Q4 2024, and up 5.75% quarter-over-quarter from $28.1 million in Q2 2025.
Agenus (AGEN) Shares Outstanding (2010 - 2026) Analysis & Trends
Agenus' Shares Outstanding (Entity) history runs 16 years deep, the most recent figure standing at $29.7 million for Q4 2025.
- On a quarterly basis, Shares Outstanding (Entity) rose 25.81% year-over-year to $29.7 million in Q4 2025; TTM through Dec 2025 was $29.7 million, a 25.81% increase from a year earlier, with the FY2025 full-year figure at $29.7 million, up 25.81% from the prior year.
- Shares Outstanding (Entity) improved to $29.7 million in Q4 2025 per AGEN's latest filing, from $28.1 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $29.7 million in Q4 2025 and bottomed at $11446.0 in Q4 2021.
- The 5-year median for Shares Outstanding (Entity) is $18908.0 (2023), against an average of $10.2 million.
- Across the five-year window, Shares Outstanding (Entity) surged 150087.22% in 2021 and slumped 99.88% in 2022, its largest moves.
- Year by year, Shares Outstanding (Entity) stood at $11446.0 in 2021, then increased by 23.07% to $14087.0 in 2022, then climbed by 27.02% to $17894.0 in 2023, then surged by 131981.54% to $23.6 million in 2024, then climbed by 25.81% to $29.7 million in 2025.
- Per Business Quant, the three latest AGEN Shares Outstanding (Entity) figures stand at $29.7 million (Q4 2025), $28.1 million (Q2 2025), and $26.6 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 47.82 Bn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.44 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 11.23 Bn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 198.10 Mn |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn | 37.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.94 Mn |
| Dec 31, 2025 | 29.73 Mn |
| Sep 30, 2025 | 31.89 Mn |
| Jun 30, 2025 | 28.12 Mn |
| Mar 31, 2025 | 24.47 Mn |
| Dec 31, 2024 | 21.47 Mn |
| Sep 30, 2024 | 21.55 Mn |
| Jun 30, 2024 | 21.06 Mn |
| Mar 31, 2024 | 20.37 Mn |
| Dec 31, 2023 | 17,894.00 |
| Sep 30, 2023 | 18,908.00 |
| Jun 30, 2023 | 17,569.00 |
| Mar 31, 2023 | 15,855.00 |
| Dec 31, 2022 | 14,087.00 |
| Sep 30, 2022 | 14,343.00 |
| Jun 30, 2022 | 13,852.00 |
| Mar 31, 2022 | 12,916.00 |
| Dec 31, 2021 | 11,446.00 |
| Sep 30, 2021 | 11,770.00 |
| Jun 30, 2021 | 11.15 Mn |